Abeona Therapeutics (ABEO)
4.82 x 1524 4.94 x 2
Post-market by (Cboe BZX)
4.84 -0.01 (-0.21%) 04/17/25 [NASDAQ]
4.82 x 1524 4.94 x 2
Post-market 4.84 unch (unch) 16:49 ET
for Thu, Apr 17th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,734 | -54,188 | -39,696 | -84,936 | -84,234 |
| Depreciation Amortization | 2,907 | 3,198 | 4,577 | 4,464 | 5,601 |
| Accounts receivable | 792 | -2,041 | 2,812 | -3,000 | N/A |
| Other Working Capital | -4,383 | -1,788 | -5,892 | -18,263 | 1,634 |
| Other Operating Activity | 8,403 | 17,810 | -5,284 | 36,070 | 41,980 |
| Operating Cash Flow | $-56,015 | $-37,009 | $-43,483 | $-65,665 | $-35,019 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,812 | 335 | -25,568 | 70,213 | -82,378 |
| PPE Investments | -2,428 | -127 | 1,604 | -4,151 | -1,336 |
| Investing Cash Flow | $-39,240 | $208 | $-23,964 | $66,062 | $-83,714 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | N/A | N/A | N/A | 1,758 |
| Common Stock Issued | 85,628 | 37,389 | 46,960 | 24,861 | 178 |
| Other Financing Activity | -1,489 | -332 | -3,787 | 0 | 0 |
| Financing Cash Flow | $104,139 | $37,057 | $43,173 | $24,861 | $1,936 |
| Beginning Cash Position | 14,811 | 14,555 | 38,829 | 13,571 | 130,368 |
| End Cash Position | 23,695 | 14,811 | 14,555 | 38,829 | 13,571 |
| Net Cash Flow | $8,884 | $256 | $-24,274 | $25,258 | $-116,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,015 | -37,009 | -43,483 | -65,665 | -35,019 |
| Capital Expenditure | -2,446 | -331 | -130 | -4,151 | -1,336 |
| Free Cash Flow | -58,461 | -37,340 | -43,613 | -69,816 | -36,355 |